| Theme | Kampo Medicine for Gastrointestinal Diseases -- Theory and Practice | |
|---|---|---|
| Title | The Action Mechanism of Rikkunshito as a Ghrelin Enhancer | |
| Publish Date | 2018/10 | |
| Author | Hiroshi Takeda | Hokkaido University Graduate School of Pharmaceutical Sciences |
| Author | Naoto Okubo | Hokkaido University Graduate School of Pharmaceutical Sciences |
| Author | Koji Nakagawa | Hokkaido University Graduate School of Pharmaceutical Sciences |
| Author | Shunsuke Ohnishi | Third Department of Internal Medicine (Gastroenterology and Hematology), Hokkaido University Graduate School of Medicine |
| Author | Naoki Fujitsuka | Tsumura " Co. |
| Author | Tomohisa Hattori | Tsumura " Co. |
| [ Summary ] | Rikkunshito has been used in Japan for treatment of upper gastrointestinal (GI) symptoms of patients with functional dyspepsia (FD), gastroesophageal reflux disease (GERD), postoperative dyspeptic symptoms of patients who have undergone GI surgery, and chemotherapy-induced dyspepsia in cancer patients. Recently, a novel mechanism of Rikkunshito was reported: oral administration of Rikkunshito potentiated orexigenic action of ghrelin through several mechanisms. In addition, several lines of evidence obtained from both animal and human studies indicated that Rikkunshito is an attractive and promising therapeutic option for patients' anorectic conditions including cisplatin-induced dyspepsia, anorexia of aging, stress-induced hypophagia, cancer cachexia-anorexia syndrome, and drug-related anorexia. This review highlighted our current understanding of the orexigenic action of Rikkunshito with special focus on its interaction with the ghrelin signaling system. | |